Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

PURPOSE: Neoadjuvant chemotherapy followed by radical cystectomy (RC) is a standard of care for the management of muscle-invasive bladder cancer (MIBC). Dose-dense cisplatin-based regimens have yielded favorable outcomes compared with standard-dose chemotherapy, yet the optimal neoadjuvant regimen r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Iyer, Gopa, Balar, Arjun V., Milowsky, Matthew I., Bochner, Bernard H., Dalbagni, Guido, Donat, S. Machele, Herr, Harry W., Huang, William C., Taneja, Samir S., Woods, Michael, Ostrovnaya, Irina, Al-Ahmadie, Hikmat, Arcila, Maria E., Riches, Jamie C., Meier, Andreas, Bourque, Caitlin, Shady, Maha, Won, Helen, Rose, Tracy L., Kim, William Y., Kania, Brooke E., Boyd, Mariel E., Cipolla, Catharine K., Regazzi, Ashley M., Delbeau, Daniela, McCoy, Asia S., Vargas, Hebert Alberto, Berger, Michael F., Solit, David B., Rosenberg, Jonathan E., Bajorin, Dean F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2018
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6049398/
https://ncbi.nlm.nih.gov/pubmed/29742009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.75.0158
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi